Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
- PMID: 15632213
- DOI: 10.1182/blood-2004-08-3088
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Comment on
-
Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia.Blood. 2004 May 15;103(10):3644-54. doi: 10.1182/blood-2003-06-2071. Epub 2004 Jan 15. Blood. 2004. PMID: 14726395 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

